Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...
GlobalData on MSN2d
Globus Medical strengthens SCS market position with $250m Nevro dealGlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.
Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
One significant factor is the recent clearance of the ExcelsiusFlex Robotic System and ACTIFY ... Zimmerman’s positive assessment of Globus Medical’s stock. In another report released on ...
Globus Medical is acquiring Nevro Corp, a spinal cord stimulator company, according to a Feb. 6 news release. Globus Medical's transaction will include all shares of Nevro, which are valued at about ...
Hosted on MSN22d
Globus Medical Surges 62.1% in a Year: What's Driving the Stock?Globus Medical GMED has seen impressive momentum ... competitive rep recruiting from prior quarters and increased implant usage through robotic pull-through. In the third quarter of 2024, Enabling ...
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ended December ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback